Magnesium

DGAP-News: Annual financial statements 2019: 9% sales growth and strongly improved EBITDA; significant milestones and growing interest in pioneering key technologies antibacterial silver coating and resorbable magnesium implants

Tuesday, June 30, 2020 - 10:08pm

In addition, the decision taken in the annual financial statements to no longer capitalize the costs of the two development projects antibacterial silver coating and resorbable magnesium implants will have a full impact on EBIDTA from the 2020 financial year.

Key Points: 
  • In addition, the decision taken in the annual financial statements to no longer capitalize the costs of the two development projects antibacterial silver coating and resorbable magnesium implants will have a full impact on EBIDTA from the 2020 financial year.
  • Against this backdrop, the Management Board expects a significantly lower level of sales and earnings for the financial year 2020.
  • It should be noted, however, that the available forecast data is characterized by a high degree of uncertainty.
  • In addition, aap Implantate AG has an innovation pipeline with promising development projects such as the antibacterial silver coating technology and magnesium-based implants.

Global Magnesium Hydroxide Market Report to 2025 - Trends, Forecast and Competitive Analysis - ResearchAndMarkets.com

Friday, June 19, 2020 - 2:04pm

Segmentation Analysis: Magnesium hydroxide market size by various segments, such as end use industry, application, purity level, product form, and regions in terms of value and volume.

Key Points: 
  • Segmentation Analysis: Magnesium hydroxide market size by various segments, such as end use industry, application, purity level, product form, and regions in terms of value and volume.
  • Regional Analysis: Magnesium hydroxide market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different end use industries, application, purity level, product form, and regions for the magnesium hydroxide market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape for the magnesium hydroxide market.

2020 Automotive Seat Frame Market Opportunity Assessment and Technology & Competitive Landscape Analysis; Featuring Faurecia, Toyota Boshoku, Johnson Controls, Magna, Camaco-Amvian, Lear, and More - ResearchAndMarkets.com

Thursday, June 18, 2020 - 1:52pm

In automotive seat frame market, various material technologies, such as magnesium alloy, steel, aluminum, and composites are used in seat frame for the passenger car, and light commercial vehicle applications.

Key Points: 
  • In automotive seat frame market, various material technologies, such as magnesium alloy, steel, aluminum, and composites are used in seat frame for the passenger car, and light commercial vehicle applications.
  • Increasing vehicle production, growing demand for lightweight seats, and high demand of seat comfort features by customers are creating opportunities for various automotive seat frame technologies.
  • This report analyzes technology maturity, degree of disruption, competitive intensity, market potential, and other parameters of various technologies in the automotive seat frame market.
  • The study includes technology readiness, competitive intensity, regulatory compliance, disruption potential, trends, forecasts and strategic implications for the global automotive seat frame technology by material technology, application, and region.

Cue Biopharma Provides Update on Ongoing Phase 1 Trial Evaluating CUE-101 in Recurrent/Metastatic Head and Neck Cancer

Monday, June 15, 2020 - 1:00pm

As of June 15, 2020, the ongoing Phase 1, first-in-human, multicenter trial has enrolled 13 patients, with a majority of patients having received multiple cycles of therapy.

Key Points: 
  • As of June 15, 2020, the ongoing Phase 1, first-in-human, multicenter trial has enrolled 13 patients, with a majority of patients having received multiple cycles of therapy.
  • In cohorts 1 through 4, patients received dosages of 0.06 mg/kg, 0.18 mg/kg, 0.54 mg/kg and 1.0 mg/kg, respectively.
  • Out of the 13 patients enrolled, there are six patients presently remaining on study for ongoing data generation.
  • This will enable us to select the optimal dose to be advanced into Part B of the Phase 1 trial.

2020 Competitive Benchmarking Report of 8 Leading Players in the Magnesium Hydroxide Market

Friday, June 12, 2020 - 4:15pm

DUBLIN, June 12, 2020 /PRNewswire/ -- The "Magnesium Hydroxide Suppliers Strategic Positioning and Leadership Quadrant" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, June 12, 2020 /PRNewswire/ -- The "Magnesium Hydroxide Suppliers Strategic Positioning and Leadership Quadrant" report has been added to ResearchAndMarkets.com's offering.
  • Major players in the magnesium hydroxide market have diversified product portfolios, strong geographical reach, and have made several strategic initiatives.
  • The dynamics of the magnesium hydroxide market extends beyond routine macro-economic elements of supply and demand.
  • This report identifies leaders, contenders, visionaries, and specialists in the magnesium hydroxide market and rates each magnesium hydroxide producer.

Magnesium Hydroxide Suppliers Leadership Quadrant: 8 Leading Market Players - ResearchAndMarkets.com

Monday, June 8, 2020 - 1:43pm

The "Magnesium Hydroxide Suppliers Strategic Positioning and Leadership Quadrant" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Magnesium Hydroxide Suppliers Strategic Positioning and Leadership Quadrant" report has been added to ResearchAndMarkets.com's offering.
  • Major players in the magnesium hydroxide market have diversified product portfolios, strong geographical reach, and have made several strategic initiatives.
  • The dynamics of the magnesium hydroxide market extends beyond routine macro-economic elements of supply and demand.
  • This report identifies leaders, contenders, visionaries, and specialists in the magnesium hydroxide market and rates each magnesium hydroxide producer.

Intrepid Congratulates East Plant Employees on Record Monthly Domestic Sales Volumes in April

Monday, June 1, 2020 - 12:00pm

Most importantly, our team accomplished this work safely and under mandated COVID-19 safety guidelines and procedures, including social distancing.

Key Points: 
  • Most importantly, our team accomplished this work safely and under mandated COVID-19 safety guidelines and procedures, including social distancing.
  • In addition, Intrepid produces a specialty fertilizer, Trio, which delivers three key nutrients, potassium, magnesium, and sulfate, in a single particle.
  • Intrepid routinely posts important information, including information about upcoming investor presentations and press releases, on its website under the Investor Relations tab.
  • Forward-looking statements in this press release include, among others, statements regarding Intrepids expectations of future Trio sales volume.

Magnesium Alloys Market Size Worth $6.6 Billion by 2027 | CAGR: 9.9%: Grand View Research, Inc.

Wednesday, May 20, 2020 - 9:05am

SAN FRANCISCO, May 20, 2020 /PRNewswire/ -- The global magnesium alloys market size is expected to reach USD 6.62 billion by 2027 registering a CAGR of 9.9%, according to a new report by Grand View Research, Inc. Increasing magnesium content per vehicle is projected to drive the demand of magnesium alloys products over the next forecast period.

Key Points: 
  • SAN FRANCISCO, May 20, 2020 /PRNewswire/ -- The global magnesium alloys market size is expected to reach USD 6.62 billion by 2027 registering a CAGR of 9.9%, according to a new report by Grand View Research, Inc. Increasing magnesium content per vehicle is projected to drive the demand of magnesium alloys products over the next forecast period.
  • Auto manufacturers are now shifting to lightweight materials, such as magnesium, aluminum, and composite materials, to reduce the emissions from vehicles.
  • Magnesium alloys have 30% lesser density than aluminum, which boosts their usage in vehicles and aerospace applications.
  • Grand View Research has segmented the global magnesium alloys market on the basis of application and region:
    Magnesium Alloys Application Outlook (Volume, Kilotons; Revenue, USD Million, 2016 - 2027)

Magnesium Alloys Market Size Worth $6.6 Billion by 2027 | CAGR: 9.9%: Grand View Research, Inc.

Wednesday, May 20, 2020 - 9:05am

SAN FRANCISCO, May 20, 2020 /PRNewswire/ -- The global magnesium alloys market size is expected to reach USD 6.62 billion by 2027 registering a CAGR of 9.9%, according to a new report by Grand View Research, Inc. Increasing magnesium content per vehicle is projected to drive the demand of magnesium alloys products over the next forecast period.

Key Points: 
  • SAN FRANCISCO, May 20, 2020 /PRNewswire/ -- The global magnesium alloys market size is expected to reach USD 6.62 billion by 2027 registering a CAGR of 9.9%, according to a new report by Grand View Research, Inc. Increasing magnesium content per vehicle is projected to drive the demand of magnesium alloys products over the next forecast period.
  • Auto manufacturers are now shifting to lightweight materials, such as magnesium, aluminum, and composite materials, to reduce the emissions from vehicles.
  • Magnesium alloys have 30% lesser density than aluminum, which boosts their usage in vehicles and aerospace applications.
  • Grand View Research has segmented the global magnesium alloys market on the basis of application and region:
    Magnesium Alloys Application Outlook (Volume, Kilotons; Revenue, USD Million, 2016 - 2027)

Arbutus Announces Single-Dose Week 12 Data in Chronic Hepatitis B Subjects with 60 mg AB-729 Demonstrating a Significant and Continuous Reduction in HBsAg

Monday, May 18, 2020 - 9:05pm

Dr. Picchio added, We are impressed by both the magnitude and continuous reduction in HBsAg achieved with a single 60 mg dose.

Key Points: 
  • Dr. Picchio added, We are impressed by both the magnitude and continuous reduction in HBsAg achieved with a single 60 mg dose.
  • We expect data from both the 60 mg multi-dose cohorts in the second half of the year.
  • We also expect week 12 90 mg single-dose data in the second half of 2020.
  • An additional cohort in Part 2 is designed to include 90 mg single-dose of AB-729 in HBV DNA positive chronic HBV subjects.